Literature DB >> 15098692

Does cross-bridge activation determine the time course of myofibrillar relaxation?

Robert Stehle1, Martina Krüger, Gabriele Pfitzer.   

Abstract

The ability of force-generating cross-bridges to activate the thin filament in cardiac muscle was tested by studying the effects of initial force and [MgADP] on force relaxation kinetics in subcellular myofibrillar bundles prepared from left ventricles of the guinea pig. Relaxation was initiated by rapidly reducing the [Ca(2+)] from pCa 4.5 to 7.5. Initiating relaxation from lower force levels during pre-steady-state force development did not significantly accelerate the kinetics of the force decay compared to relaxations initiated from steady-state force development. This suggests that the force-generating cross-bridges which become formed during maximally Ca(2+)-activated steady-state contractions do not maintain thin filament activation for significant enough times after Ca(2+)-removal to exert a rate-limiting influence on force relaxation kinetics. Adding 2 mM MgADP to solutions slowed down relaxation kinetics approximately 4-fold. To differentiate whether these slower kinetics result from either (1) MgADP favoring accumulation of cross-bridges during the preceding contraction in a state of activating capability or (2) slow-down of cross-bridge turnover by the presence of the product MgADP during relaxation, the [MgADP] was either increased or removed at the time of Ca(2+)-removal. The addition of 2 mM MgADP to activating solutions (subsequent relaxation in the absence of MgADP) slowed-down the kinetics of the initial, slow, linear force decay following Ca(2+)-removal approximately 1.5-fold, suggesting that the high [MgADP] during contraction favors formation of cross-bridges which contribute in rate-limiting early relaxation kinetics by transiently sustaining thin filament activation. On the other hand, the addition of 2 mM MgADP to the relaxing solution (preceding Ca(2+)-activation in absence of MgADP) slowed-down the kinetics of the initial force decay approximately 3-fold, more similar to the kinetics observed in the continuous presence of 2 mM MgADP both before and after Ca(2+)-removal. This suggest that, despite some influence of cross-bridge activation, the main effect of MgADP on relaxation kinetics results from product inhibition of cross-bridge turnover. In summary, whereas under certain conditions (high [MgADP]) cross-bridge activation of the thin filament can weakly take part in rate-limiting relaxation kinetics induced by complete Ca(2+)-removal, cross-bridge activation does not influence relaxation kinetics under more physiologically normal conditions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15098692     DOI: 10.1007/978-1-4419-9029-7_43

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  9 in total

1.  Mechanical properties of sarcomeres during cardiac myofibrillar relaxation: stretch-induced cross-bridge detachment contributes to early diastolic filling.

Authors:  R Stehle; J Solzin; B Iorga; D Gomez; N Blaudeck; G Pfitzer
Journal:  J Muscle Res Cell Motil       Date:  2006-08-09       Impact factor: 2.698

Review 2.  S100A1: a regulator of striated muscle sarcoplasmic reticulum Ca2+ handling, sarcomeric, and mitochondrial function.

Authors:  Mirko Völkers; David Rohde; Chelain Goodman; Patrick Most
Journal:  J Biomed Biotechnol       Date:  2010-03-28

3.  Kinetic mechanism of the Ca2+-dependent switch-on and switch-off of cardiac troponin in myofibrils.

Authors:  Johannes Solzin; Bogdan Iorga; Eva Sierakowski; Diana P Gomez Alcazar; Daniel F Ruess; Torsten Kubacki; Stefan Zittrich; Natascha Blaudeck; Gabriele Pfitzer; Robert Stehle
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

4.  Insights into the kinetics of Ca2+-regulated contraction and relaxation from myofibril studies.

Authors:  Robert Stehle; Johannes Solzin; Bogdan Iorga; Corrado Poggesi
Journal:  Pflugers Arch       Date:  2009-01-23       Impact factor: 3.657

5.  PKA phosphorylation of cardiac troponin I modulates activation and relaxation kinetics of ventricular myofibrils.

Authors:  Vijay Rao; Yuanhua Cheng; Steffen Lindert; Dan Wang; Lucas Oxenford; Andrew D McCulloch; J Andrew McCammon; Michael Regnier
Journal:  Biophys J       Date:  2014-09-02       Impact factor: 4.033

6.  Differences in Contractile Function of Myofibrils within Human Embryonic Stem Cell-Derived Cardiomyocytes vs. Adult Ventricular Myofibrils Are Related to Distinct Sarcomeric Protein Isoforms.

Authors:  Bogdan Iorga; Kristin Schwanke; Natalie Weber; Meike Wendland; Stephan Greten; Birgit Piep; Cristobal G Dos Remedios; Ulrich Martin; Robert Zweigerdt; Theresia Kraft; Bernhard Brenner
Journal:  Front Physiol       Date:  2018-01-19       Impact factor: 4.566

Review 7.  Sarcomeric determinants of striated muscle relaxation kinetics.

Authors:  Corrado Poggesi; Chiara Tesi; Robert Stehle
Journal:  Pflugers Arch       Date:  2004-11-30       Impact factor: 3.657

8.  2-Deoxyadenosine triphosphate restores the contractile function of cardiac myofibril from adult dogs with naturally occurring dilated cardiomyopathy.

Authors:  Yuanhua Cheng; Kaley A Hogarth; M Lynne O'Sullivan; Michael Regnier; W Glen Pyle
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-23       Impact factor: 4.733

9.  Why make a strong muscle weaker?

Authors:  Bogdan Iorga; Theresia Kraft
Journal:  J Gen Physiol       Date:  2021-06-09       Impact factor: 4.086

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.